CAS: 891016-02-7
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]cyclohexyl}benzenesulfonamide REF: IN-DA01BV7ICAS: 891016-02-7 | 95% | A consultar | Lun 24 Mar 25 |
 | ML-SI3 REF: TM-T9226CAS: 891016-02-7 | 99.75% | 49,00 €~560,00 € | Lun 31 Mar 25 |
 | N-{2-[4-(2-Methoxyphenyl)-1-piperazinyl]cyclohexyl}benzenesulfonamide REF: 3D-RKB01602CAS: 891016-02-7 | Min. 95% | - - - | Producto descatalogado |
![N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]cyclohexyl}benzenesulfonamide](https://static.cymitquimica.com/products/IN/thumb/DA01BV7I.jpg)
N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]cyclohexyl}benzenesulfonamide
CAS:891016-02-7
Fórmula:
C23H31N3O3S
Pureza:
95%
Forma y color:
Solid
Peso molecular:
429.5755
Ref: IN-DA01BV7I
| 1g | A consultar | ||
| 100mg | 172,00 € | ||
| 250mg | 226,00 € |
Entrega estimada en Estados Unidos, el Lunes 24 de Marzo de 2025
ML-SI3
CAS:891016-02-7
CCG-143140 is a GLP-1 receptor inverse agonists.
Fórmula:
C23H31N3O3S
Pureza:
99.75%
Forma y color:
Solid
Peso molecular:
429.58
Ref: TM-T9226
| 2mg | 49,00 € | ||
| 5mg | 73,00 € | ||
| 10mg | 116,00 € | ||
| 25mg | 235,00 € | ||
| 50mg | 373,00 € | ||
| 100mg | 560,00 € | ||
| 1mL*10mM (DMSO) | 82,00 € |
Entrega estimada en Estados Unidos, el Lunes 31 de Marzo de 2025
![N-{2-[4-(2-Methoxyphenyl)-1-piperazinyl]cyclohexyl}benzenesulfonamide](https://static.cymitquimica.com/products/3D/thumb/RKB01602.jpg)
N-{2-[4-(2-Methoxyphenyl)-1-piperazinyl]cyclohexyl}benzenesulfonamide
CAS:891016-02-7
Versatile small molecule scaffold
Fórmula:
C23H31N3O3S
Pureza:
Min. 95%
Peso molecular:
429.6 g/mol
Ref: 3D-RKB01602
| 1g | Descatalogado | Solicitar información | |
| 10mg | Descatalogado | Solicitar información | |
| 25mg | Descatalogado | Solicitar información | |
| 50mg | Descatalogado | Solicitar información | |
| 100mg | Descatalogado | Solicitar información | |
| 250mg | Descatalogado | Solicitar información |
